Rock Springs Capital Management LP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$23,286,952
-24.4%
1,211,600
+0.0%
0.62%
-14.9%
Q2 2023$30,793,788
-21.0%
1,211,400
+12.4%
0.73%
-21.2%
Q1 2023$38,966,085
-8.7%
1,077,9000.0%0.93%
-9.4%
Q4 2022$42,684,840
+16.4%
1,077,900
+37.0%
1.03%
+8.4%
Q3 2022$36,674,000
+8.2%
787,000
+1.8%
0.95%
-4.0%
Q2 2022$33,894,000
-35.1%
773,300
+7.2%
0.99%
-25.0%
Q1 2022$52,186,000
-9.8%
721,500
+1.1%
1.31%
-1.7%
Q4 2021$57,884,000
-21.8%
714,000
+12.3%
1.34%
-14.1%
Q3 2021$73,983,000
-16.0%
635,700
+19.7%
1.56%
-10.6%
Q2 2021$88,034,000
+30.1%
531,000
+9.5%
1.74%
+17.9%
Q1 2021$67,658,000
-1.0%
485,000
+22.8%
1.48%
+1.8%
Q4 2020$68,375,000
+27.2%
395,000
+2.3%
1.45%
+6.3%
Q3 2020$53,770,000
+16.6%
386,0000.0%1.36%
+7.8%
Q2 2020$46,115,000
+33.3%
386,000
+11.6%
1.26%
-11.5%
Q1 2020$34,593,000
+5.5%
346,000
+24.0%
1.43%
+38.0%
Q4 2019$32,794,000
+57.3%
279,000
+15.1%
1.04%
+24.7%
Q3 2019$20,848,000
+64.5%
242,500
+24.0%
0.83%
+81.0%
Q2 2019$12,674,000
+484.3%
195,500
+463.4%
0.46%
+446.4%
Q1 2019$2,169,00034,7000.08%
Other shareholders
NEVRO CORP shareholders Q2 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders